
Patierno's current translational research interests are focused on the genomics molecular biology of cancer disparities, cancer biology, molecular pharmacology and targeted experimental therapeutics to control prostate, breast and lung tumor aggressiveness. He is an internationally recognized expert in cancer control, cancer causation and molecular carcinogenesis, which includes a broad spectrum of laboratory and population level research. Patierno is also actively engaged in cancer health disparities and healthcare delivery research focused on patient navigation, survivorship, community-based interventions, mHealth, implementation sciences, cancer care economics, and policy.
Education and Training
- Postdoctoral Training, Norris Comprehensive Cancer, University of Southern California, 1986 - 1988
- Ph.D., University of Texas Medical School, Houston, 1985
- B.S., University of Connecticut, 1981
Grants
- Race-related differential RNA splicing: novel targets for precision oncology in non-small cell lung cancer
- Duke University Program in Environmental Health
- Duke Cancer Health Disparities P20 SPORE
- Race-Related Alternative Splicing: Novel Targets in Prostate Cancer
- Small Molecule Targeting Of RNAs Driving Tumor Aggressiveness
- Reducing prostate cancer aggressiveness via aptamer-mediated nuclear delivery of splice-switching oligonucleotides
- Ancestry-related RNA splicing and immune expression in metastatic breast cancer
- Targeting RNA splicing in race-related aggressive and lethal prostate cancer
- Race-related germline genetic variation and response to secondary hormonal therapy in metastatic castration-resistant prostate cancer